Are you age or majority in your province (19+ or 18+ in Alberta and Quebec)?
It isn’t everyday that we are able to connect with scores cannabis leaders in one day for deep conversations and the surfacing of thoughtful insights - but last Friday was one of those rare opportunities.
In partnership with Ample Organics, Business of Cannabis produced Sessions a full-day of live-streamed interviews.
Sessions gave us the unique opportunity to get a glimpse of the state of the industry from a wide array of perspectives. Here are three things we learned:
A common thread through nearly all Sessions interviews was the presence of a very real, and very wide education gap. This gap is prevalent for current consumers choosing legal versus illegal products, for those looking to treat animals with cannabis, for those using cannabis as an enhancement to sex and for those learning about medical cannabis. Education is paramount in evolving the industry and an education and information gap exists. In that gap are significant challenges for the sector...and significant opportunities.
Legalization in Canada may be in the early innings, but the next wave of products are going to give consumers many more choices - and with the choices it will be incumbent on Canadian businesses to stay focused on what they do well, but also be willing to adapt to where consumers’ tastes go. Vape pens, beverages, chocolates, lotions, creams, topicals, sprays and patches - all topics covered in Sessions - could be make-or-break for Canadian companies in the coming year.
The past year has been one of rapid change and advancement for the Canadian cannabis industry. The federal approach to cannabis in Canada opened up capital markets here before anywhere else - allowing capital to flow into the Canadian sector. But it also allowed capital to flow into players from around the world - and increasingly those dollars are flowing to non-Canadian players. Regulatory hurdles coupled with a rapid expansion of worldwide markets provides incredible opportunities to Canadian companies - and a strong push for non-Canadian companies to sprint ahead. The future is undecided and uncertain.
The full line up of Sessions interviews is below. Watch on…
Terry Donnelly, Hill Street Bev. Co.
Lisa Campbell, Lifford Cannabis Solutions
Trevor Green, OneLeaf
Matt Bannister, Last Call Analytics
Session 2 | David Hyde, 3|Sixty Secure
Session 3 | Greg Engel, Organigram
Session 4 | Fern Glowinsky, Merrco Payments
Session 5 | Mary Durocher, Fox D Consulting
Session 6 | Steve DeAngelo, Harborside
Alison McMahon, Cannabis At Work
David Purcell, KPU
Tom Ritchie, Ample Organics
Session 9 | Bill Panagiotakopoulos, Kevin Keagan + Roger Ferreira, beleave inc.
Session 10 | Andrew Muroff, Strainprint Technologies
Session 11 | Andy Williams, Angela Fehr + Scott Langegger, AgMedica
Session 12 | Deepak Anand + Michael Garbuz, Materia Ventures
Alexei Chinkarenko + Sergey Mokin, Purileaf Brand
Session 14 | Tabitha Fritz
Session 15 | Alex Blumenstein + Brett Chang, Leaf Forward
Session 16 | Mark Finkelstein, CannaSupplies
Session 17 | Jeff Jacobson, Cronos Group
Session 18 | Dr. Ian Sandler, DVM, Grey Wolf Animal Health
Session 19 | Larry Lisser, HelloMD
Session 20 | Matt Nordgren, Arcadian Fund
Session 21 | James O’Hara
Session 22 | Robert Laurie, Ad Lucem Law